KBP Biosciences
13 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) (NCT04968184) | KBP Biosciences | 2021-11-05 |
| Mass Balance Study of KBP-5074 in Healthy Male Subjects (NCT04634812) | KBP Biosciences | 2020-12-03 |
| Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects (NCT04606537) | KBP Biosciences | 2020-10-24 |
| Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment (NCT04534699) | KBP Biosciences | 2020-08-27 |
| A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects (NCT04532957) | KBP Biosciences | 2020-08-11 |
| Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease (NCT03574363) | KBP Biosciences | 2018-04-25 |
| Bioavailability of KBP-5074 Tablet vs Capsule Formulations (NCT03340753) | KBP Biosciences | 2017-10-26 |
Track KBP Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.